Effets indésirables oculaires des traitements systémiques: une mise à jour

A. Rousseau; M. Labetoulle

doi:10.1016/j.jfo.2015.05.004

Effets indésirables oculaires des traitements systémiques: une mise à jour

A. Rousseau
, M. Labetoulle

Assistance Publique-Hôpitaux de Paris

Résultats de recherche: Contribution à un journal › Article de révision › Revue par des pairs

6 Citations (Scopus)

Résumé

The ocular side effects of systemic treatments are numerous and sometimes severe. The prescriber and the ophthalmologist should be aware of ocular side effects of systemic treatments in order to inform their patients accordingly, implement appropriate ophthalmological monitoring and/or treatment and if necessary, adapt the therapeutic management. In this review, we describe the recently recognized ophthalmic complications of systemic treatments, except for optic neuropathies.

Titre traduit de la contribution	Recently recognized ophthalmic complications of systemic treatments
langue originale	Français
Pages (de - à)	876-882
Nombre de pages	7
journal	Journal Francais d'Ophtalmologie
Volume	38
Numéro de publication	9
Les DOIs	https://doi.org/10.1016/j.jfo.2015.05.004
état	Publié - 1 nov. 2015
Modification externe	Oui

mots-clés

Bisphosphonate
Cancer targettherapy
Etanercept
Fingolimod
Nicorandil
Ocular adverseeffects
Phosphodiesteraseinhibitors
Topiramate

Accès au document

10.1016/j.jfo.2015.05.004

Contient cette citation

@article{6336a94dc6f049e29c4d32b97ff1430c,

title = "Effets ind{\'e}sirables oculaires des traitements syst{\'e}miques: une mise {\`a} jour",

abstract = "The ocular side effects of systemic treatments are numerous and sometimes severe. The prescriber and the ophthalmologist should be aware of ocular side effects of systemic treatments in order to inform their patients accordingly, implement appropriate ophthalmological monitoring and/or treatment and if necessary, adapt the therapeutic management. In this review, we describe the recently recognized ophthalmic complications of systemic treatments, except for optic neuropathies.",

keywords = "Bisphosphonate, Cancer targettherapy, Etanercept, Fingolimod, Nicorandil, Ocular adverseeffects, Phosphodiesteraseinhibitors, Topiramate",

author = "A. Rousseau and M. Labetoulle",

note = "Publisher Copyright: {\textcopyright} 2015 Elsevier Masson SAS.",

year = "2015",

month = nov,

day = "1",

doi = "10.1016/j.jfo.2015.05.004",

language = "Fran{\c c}ais",

volume = "38",

pages = "876--882",

journal = "Journal Francais d'Ophtalmologie",

issn = "0181-5512",

publisher = "Elsevier Masson s.r.l.",

number = "9",

}

TY - JOUR

T1 - Effets indésirables oculaires des traitements systémiques

T2 - une mise à jour

AU - Rousseau, A.

AU - Labetoulle, M.

PY - 2015/11/1

Y1 - 2015/11/1

N2 - The ocular side effects of systemic treatments are numerous and sometimes severe. The prescriber and the ophthalmologist should be aware of ocular side effects of systemic treatments in order to inform their patients accordingly, implement appropriate ophthalmological monitoring and/or treatment and if necessary, adapt the therapeutic management. In this review, we describe the recently recognized ophthalmic complications of systemic treatments, except for optic neuropathies.

AB - The ocular side effects of systemic treatments are numerous and sometimes severe. The prescriber and the ophthalmologist should be aware of ocular side effects of systemic treatments in order to inform their patients accordingly, implement appropriate ophthalmological monitoring and/or treatment and if necessary, adapt the therapeutic management. In this review, we describe the recently recognized ophthalmic complications of systemic treatments, except for optic neuropathies.

KW - Bisphosphonate

KW - Cancer targettherapy

KW - Etanercept

KW - Fingolimod

KW - Nicorandil

KW - Ocular adverseeffects

KW - Phosphodiesteraseinhibitors

KW - Topiramate

U2 - 10.1016/j.jfo.2015.05.004

DO - 10.1016/j.jfo.2015.05.004

M3 - Article de révision

C2 - 26507783

AN - SCOPUS:84989182922

SN - 0181-5512

VL - 38

SP - 876

EP - 882

JO - Journal Francais d'Ophtalmologie

JF - Journal Francais d'Ophtalmologie

IS - 9

ER -

Effets indésirables oculaires des traitements systémiques: une mise à jour

Résumé

mots-clés

Accès au document

Empreinte digitale

Contient cette citation